Display Settings:

Format

Send to:

Choose Destination
    Strahlenther Onkol. 1991 Mar;167(3):165-8.

    [Incidence of osteoradionecrosis after combined radiotherapy-chemotherapy of head and neck tumors].

    [Article in German]

    Source

    Universitätsklinik für Strahlentherapie und Strahlenbiologie, Universität Wien, Osterreich.

    Abstract

    Combined modality therapy, consisting of radiation, chemotherapy and surgery are used to treat primary tumours aiming to preserve function and increase tumour control. In the present prospective trial 112 patients underwent combined preoperative radio-chemotherapy, 35 patients were treated with combined radio-chemotherapy as only treatment. At a median follow-up of 26 months eight patients (2.8%) have developed an osteo-radionecrosis, which is comparable with data from the literature. When known risk factors are avoided the incidence of osteo-radionecrosis is not increased following combined therapy. The most important factors for development of osteo-radionecrosis following radio-chemotherapy are large tumours and tumour infiltration in the mandible.

    PMID:
    1901670
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk